Inhibition of normal natural killer cytotoxicity by sera from hemophilic patients.
In this study we searched for circulating antibodies or other serum factors that could account for the natural killer (NK) defect observed in hemophiliacs (He) infected with the human immunodeficiency virus (HIV). We analyzed the effect of negative or positive sera for HIV from He on normal NK activity. We showed that sera from He interfered with normal NK cytotoxicity. The inhibitory activity was higher in HIV+ sera and increased as the HIV disease progressed. HIV- sera also inhibited NK function, although to a lesser extent than HIV+, and it was probably due to isoimmunization through replacement treatment with plasma-derived concentrates. For each individual, no direct correlation was found between NK inhibition (NK-INH) of sera and the NK activity of He peripheral blood mononuclear cells (PBMC). Furthermore, He serum was poorly inhibitory on autologous PBMC. Preincubation of allogenic effector or target cells with He sera revealed that the inhibitory effect was the result of the reaction with these cells. A positive correlation was found by comparing NK-INH of whole He sera with the serum levels of circulating immune complexes. When the NK-INH assay was performed using the same concentration of DEAE-purified IgG from N, HIV- or HIV+, we found that HIV+ AIDS IgG was more inhibitory than the others.
Vulcano
M
M
Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina.
Olabuenaga
S E
SE
Galassi
N
N
Felippo
M
M
Perez Bianco
R
R
de Bracco
M M
MM
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000150:complications; D000936:Antigen-Antibody Complex / Q000097:blood / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D003602:Cytotoxicity, Immunologic; D015658:HIV Infections / Q000097:blood* / Q000150:complications; D006679:HIV Seropositivity; D006467:Hemophilia A / Q000097:blood* / Q000150:complications; D002836:Hemophilia B / Q000097:blood / Q000150:complications; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology* / Q000302:isolation & purification; D007153:Immunologic Deficiency Syndromes / Q000209:etiology*; D007694:Killer Cells, Natural / Q000276:immunology* / Q000473:pathology; D007963:Leukocytes, Mononuclear / Q000276:immunology
D000936:Antigen-Antibody Complex; D007074:Immunoglobulin G